Takeda, a global leader in the pharmaceutical industry, proudly announced the appointment of Milano Furuta as the company’s new Chief Financial Officer (CFO). This strategic leadership transition marks a significant milestone in Furuta’s distinguished 13-year journey with Takeda, where his profound dedication and innovative strategies have played pivotal roles in driving the company’s mission to provide better health solutions and a brighter future for the world.
Milano Furuta’s career at Takeda has been characterized by a series of progressive leadership roles, each contributing to his deep understanding of the pharmaceutical landscape and Takeda’s operational dynamics. Prior to his current appointment as CFO, Furuta served as the President of the Japan Pharma Business Unit from April 2021, where he demonstrated exceptional leadership in steering Takeda’s strategic direction within the Japanese market. Before this role, he held the positions of Corporate Strategy Officer and Chief of Staff, and Country Manager for Takeda Pharma AB in Sweden, showcasing his versatile leadership capabilities and strategic acumen across diverse market environments.
Furuta’s journey with Takeda also included impactful roles in Mexico as Business Unit Manager for Diabetes and Sales & Marketing Manager, where his contributions significantly bolstered Takeda’s market presence and operational efficiency. His early roles in the company encompassed strategic planning and global business development, laying a strong foundation for his later achievements in senior leadership positions.
Before joining Takeda, Milano Furuta garnered valuable experience and insights from his roles at Mizuho Capital Partners and Taiyo Pacific Partners, as well as his foundational years at the Industrial Bank of Japan and Mizuho Bank. His tenure at these institutions equipped him with a robust financial, strategic, and managerial skill set that he would later apply to his roles in the pharmaceutical industry.